Project
Beat-meso ETOP 13-18
Ongoing - recruitment closed · 2019 until 2099
Früh Martin, Breuss Kim, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2019
End Date
2099
Financing
Industry
Labels
lung cancer
Brief description/objective
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment for advanced malignant pleural mesothelioma